Cipla to Market Lilly's Weight-Loss Drug Tirzepatide in India Under New Brand
Under the agreement, Lilly will continue to manufacture and supply the drug, while Cipla will use its extensive distribution network to broaden access beyond metropolitan centres.
Tirzepatide In India | 24/10/2025 | By Darshana | 626
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy